EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Peripherally-derived LGI1-reactive monoclonal antibodies cause epileptic seizures in vivo

Manoj Upadhya, Toni Kirmann, Max A Wilson iD, Christian M Simon, Divya Dhangar, Christian Geis, Robyn Williams, Gavin Woodhall iD, Stefan Hallermann, Sarosh R Irani iD, Sukhvir K Wright iD

Brain · 01.08.2024 · 147 (8) · 2636-2642

DOI: 10.1093/brain/awae129 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, online erschienen am 25.04.2024. Verfasst von Manoj Upadhya und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Health and Neurodevelopment, School of Health and Life Sciences, Aston University, Birmingham, B4 7ET, UK. Hauptthemen laut MEDLINE: Rats, Wistar, Intracellular Signaling Peptides and Proteins, Antibodies, Monoclonal, Autoantibodies. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, National Institute for Health Research, European Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

One striking clinical hallmark in patients with autoantibodies to leucine-rich glioma inactivated 1 (LGI1) is the very frequent focal seizure semiologies, including faciobrachial dystonic seizures (FBDS), in addition to the amnesia. Polyclonal serum IgGs have successfully modelled the cognitive changes in vivo but not seizures. Hence, it remains unclear whether LGI1-autoantibodies are sufficient to cause seizures. We tested this with the molecularly precise monoclonal antibodies directed against LGI1 [LGI1-monoclonal antibodies (mAbs)], derived from patient circulating B cells. These were directed towards both major domains of LGI1, leucine-rich repeat and epitempin repeat, and infused intracerebroventricularly over 7 days into juvenile male Wistar rats using osmotic pumps. Continuous wireless EEG was recorded from a depth electrode placed in hippocampal CA3 plus behavioural tests for memory and hyperexcitability were performed. Following infusion completion (Day 9), post-mortem brain slices were studied for antibody binding and effects on Kv1.1. The LGI1-mAbs bound most strongly in the hippocampal CA3 region and induced a significant reduction in Kv1.1 cluster number in this subfield. By comparison to control-Ab injected rats video-EEG analysis over 9 days revealed convulsive and non-convulsive seizure activity in rats infused with LGI1-mAbs, with a significant number of ictal events. Memory was not impaired in the novel object recognition test. Peripherally-derived human LGI1-mAbs infused into rodent CSF provide strong evidence of direct in vivo epileptogenesis with molecular correlations. These findings fulfill criteria for LGI1-antibodies in seizure causation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rats, WistarIntracellular Signaling Peptides and ProteinsAntibodies, MonoclonalAutoantibodiesAnimalsMaleRatsHumansSeizuresElectroencephalographyProteinsEpilepsy

Stichwörter der Autor:innen

LGI1-Ab encephalitisautoimmune-associated epilepsyfaciobrachial dystonic seizures (FBDS)kv1 1seizures

Substanzen

LGI1 protein, humanIntracellular Signaling Peptides and ProteinsAntibodies, MonoclonalAutoantibodiesProteins

Autor:innen und Institutionen

  • Institute of Health and Neurodevelopment, School of Health and Life Sciences, Aston University, Birmingham, B4 7ET, UK.
  • Faculty of Medicine, Carl-Ludwig-Institute of Physiology, Leipzig University, Leipzig 04103, Germany.
  • Department of Neurology, Section Translational Neuroimmunology, Jena University Hospital, Jena 07747, Germany.
  • Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, OX3 9DU, UK.
  • Departments of Neurology and Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA.
  • Department of Neurology, Birmingham Women's and Children's Hospital NHS Trust, Birmingham, B4 6NH, UK.

ORCID-Profile: Max A Wilson, Gavin Woodhall, Sarosh R Irani, Sukhvir K Wright

Förderung

  • Wellcome Trust
  • National Institute for Health Research
  • European Research Council
  • SMA Europe
  • Oxford Biomedical Research Centre
  • German Research Foundation
  • Medical Research Council
  • Schilling Foundation

Zitieren

APA

Upadhya, M., Kirmann, T., Wilson, M. A., Simon, C. M., Dhangar, D., Geis, C., Williams, R., Woodhall, G., Hallermann, S., Irani, S. R., & Wright, S. K. (2024). Peripherally-derived LGI1-reactive monoclonal antibodies cause epileptic seizures in vivo. Brain, 147(8), 2636-2642. https://doi.org/10.1093/brain/awae129

Vancouver

Upadhya M, Kirmann T, Wilson MA, Simon CM, Dhangar D, Geis C, et al. Peripherally-derived LGI1-reactive monoclonal antibodies cause epileptic seizures in vivo. Brain. 2024;147(8):2636-2642. doi:10.1093/brain/awae129

BibTeX
@article{Upadhya2024,
  author = {Upadhya, Manoj and Kirmann, Toni and Wilson, Max A and Simon, Christian M and Dhangar, Divya and Geis, Christian and Williams, Robyn and Woodhall, Gavin and Hallermann, Stefan and Irani, Sarosh R and Wright, Sukhvir K},
  title = {Peripherally-derived LGI1-reactive monoclonal antibodies cause epileptic seizures in vivo},
  journal = {Brain},
  year = {2024},
  volume = {147},
  number = {8},
  pages = {2636--2642},
  doi = {10.1093/brain/awae129}
}
Kostenlos starten →